| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.075 | 0.6 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |